Next-generation Sequencing of Urologic Cancers: Next Is Now

Slides:



Advertisements
Similar presentations
Volume 46, Issue 6, Pages (December 2004)
Advertisements

Early Detection of Prostate Cancer in 2007
Volume 59, Issue 2, Pages (February 2011)
Volume 51, Issue 2, Pages (February 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 58, Issue 4, Pages (October 2010)
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Testosterone Therapy in Men With Prostate Cancer
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Volume 61, Issue 6, Pages (June 2012)
Volume 67, Issue 1, Pages (January 2015)
Volume 53, Issue 4, Pages (April 2008)
Volume 70, Issue 1, Pages (July 2016)
Volume 60, Issue 1, Pages (July 2011)
Volume 61, Issue 5, Pages (May 2012)
Volume 53, Issue 5, Pages (May 2008)
Volume 64, Issue 4, Pages (October 2013)
Let the Games Begin (with EAU Approval)
Hormone Therapy for Prostate Cancer: Exploring Current Controversies
Prostate Cancer Epidemic in Sight?
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Elizabeth K. Bancroft, Rosalind A. Eeles
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Volume 70, Issue 3, Pages (September 2016)
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 54, Issue 5, Pages (November 2008)
Volume 68, Issue 3, Pages (September 2015)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 69, Issue 6, Pages (June 2016)
Shaheen Alanee, Kasmintan Schrader, Kenneth Offit  European Urology 
Inflammation and Chronic Prostatic Diseases: Evidence for a Link?
Counselling the Prostate Cancer Patient
Prostate Cancer Epidemic in Sight?
Volume 70, Issue 1, Pages e27-e28 (July 2016)
Volume 74, Issue 3, Pages (September 2018)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 53, Issue 6, Pages (June 2008)
Mark A. Rubin, Gabriele Girelli, Francesca Demichelis  European Urology 
Leonard S. Marks, Jiaoti Huang  European Urology 
Volume 53, Issue 4, Pages (April 2008)
Volume 63, Issue 3, Pages (March 2013)
Volume 62, Issue 4, Pages (October 2012)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
The Lethal Clone in Prostate Cancer: Redefining the Index
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl  European Urology 
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Testicular Cancer Variations in Time and Space in Europe
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Economic Burden of Bladder Cancer Across the European Union
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Volume 51, Issue 2, Pages (February 2007)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Next-generation Sequencing of Urologic Cancers: Next Is Now Francisco X. Real, Paul C. Boutros, Núria Malats  European Urology  Volume 66, Issue 1, Pages 4-7 (July 2014) DOI: 10.1016/j.eururo.2014.03.028 Copyright © 2014 European Association of Urology Terms and Conditions

Fig. 1 Summary of ongoing projects in prostate cancer (PCa) using next-generation sequencing. A French project focuses on PCa within the French Caribbean islands; a British project studies intratumoural and ethnic heterogeneity; a German project analyses early-onset PCa; and a Canadian project focuses on intratumoural heterogeneity and risk stratification of intermediate-risk PCa. The US Cancer Genome Atlas Research Network project provides a large-scale survey across all localised risk groups and will serve as a useful validation cohort. Finally, Stand Up to Cancer has created two PCa “dream teams,” one focusing on metastatic disease and the other on linking genomic profiles to treatment selection. CPRC=castration-resistant prostate cancer; ICGC=International Cancer Genome Consortium; PINs=prostatic intraepithelial neoplasia; TCGA=The Cancer Genome Atlas. European Urology 2014 66, 4-7DOI: (10.1016/j.eururo.2014.03.028) Copyright © 2014 European Association of Urology Terms and Conditions